Talazoparib Related Products


Talazoparib is a targeted cancer therapy used primarily in the treatment of certain types of breast cancer, specifically hereditary BRCA-mutated breast cancer. It is a PARP inhibitor (Poly (ADP-ribose) polymerase inhibitor), which works by blocking the PARP enzyme that helps repair damaged DNA in cell.


SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Talazoparib, pharmacopeial and non-pharmacopeial Talazoparib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Talazoparib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.

Talazoparib-related products are thoroughly characterized. Talazoparib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.

Talazoparib d4

N° de SZ CAT:: SZ-T057D01
Número CAS: NA
Mol.F.: C19H10D4F2N6O
Peso Molecular: 384.4
Status de Fatura: Custom Synthesis

Talazoparib Tosylate

N° de SZ CAT:: SZ-T057001
Número CAS: 1373431-65-2
Mol.F.: C19H14F2N6O : C7H8O3S
Peso Molecular: 380.4 : 172.2
Status de Fatura: Custom Synthesis
Rel. CAS No: 1207456-01-6 (free base) ; 1373329-48-6 (HCl salt)

Talazoparib Nitroso Impurity 1

N° de SZ CAT:: SZ-T057002
Número CAS: NA
Mol.F.: C19H13F2N7O2
Peso Molecular: 409.4
Status de Fatura: Custom Synthesis
categories
products.recentlyviewedproducts